SinoMab BioScience Limited (3681.HK)

HKD 1.03

(-1.9%)

Net Income Summary of SinoMab BioScience Limited

SinoMab BioScience Limited's latest annual net income in 2023 was -243.11 Million CNY , up 14.45% from previous year.
SinoMab BioScience Limited's latest quarterly net income in 2024 Q2 was -90.62 Million CNY , down 0.0% from previous quarter.
SinoMab BioScience Limited reported an annual net income of -284.15 Million CNY in 2022, up 1.4% from previous year.
SinoMab BioScience Limited reported an annual net income of -288.19 Million CNY in 2021, down -135.07% from previous year.
SinoMab BioScience Limited reported a quarterly net income of -109.01 Million CNY for 2023 Q4, down 0.0% from previous quarter.
SinoMab BioScience Limited reported a quarterly net income of -134.09 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Net Income Chart of SinoMab BioScience Limited (2023 - 2017)

Historical Annual Net Income of SinoMab BioScience Limited (2023 - 2017)

Year	Net Income	Net Income Growth
2023	-243.11 Million CNY	14.45%
2022	-284.15 Million CNY	1.4%
2021	-288.19 Million CNY	-135.07%
2020	-122.6 Million CNY	56.0%
2019	-278.62 Million CNY	-233.24%
2018	-83.61 Million CNY	-74.28%
2017	-47.97 Million CNY	0.0%

Year	Net Income	Net Income Growth
2024 Q2	-90.62 Million CNY	0.0%
2023 Q4	-109.01 Million CNY	0.0%
2023 Q2	-134.09 Million CNY	0.0%
2023 FY	-243.11 Million CNY	14.45%
2022 FY	-284.15 Million CNY	1.4%
2022 Q4	-140.36 Million CNY	0.0%
2022 Q2	-143.79 Million CNY	0.0%
2021 Q2	-114.4 Million CNY	0.0%
2021 Q4	-173.79 Million CNY	0.0%
2021 FY	-288.19 Million CNY	-135.07%
2020 Q2	-80.84 Million CNY	0.0%
2020 FY	-122.6 Million CNY	56.0%
2020 Q4	-41.76 Million CNY	0.0%
2019 Q2	-46.34 Million CNY	32.9%
2019 FY	-278.62 Million CNY	-233.24%
2019 Q4	-229.93 Million CNY	0.0%
2019 Q1	-69.07 Million CNY	0.0%
2018 Q1	-20.9 Million CNY	0.0%
2018 FY	-83.61 Million CNY	-74.28%
2018 Q4	-69.07 Million CNY	0.0%
2018 Q2	-20.9 Million CNY	0.0%
2017 FY	-47.97 Million CNY	0.0%
2017 Q1	-11.99 Million CNY	0.0%
2017 Q2	-11.99 Million CNY	0.0%
2017 Q4	-20.9 Million CNY	0.0%
2016 Q4	-11.99 Million CNY	0.0%

Peer Net Income Comparison of SinoMab BioScience Limited

Name	Net Income	Net Income Difference
Uni-Bio Science Group Limited	70.87 Million HKD	443.009%
CK Life Sciences Int'l., (Holdings) Inc.	17.25 Million HKD	1509.339%